Sei qui: Home Page -> La Propolis - Studi, ricerche e articoli scientifici sull'impiego del Polline nelle affezioni della PROSTATA

Studi, ricerche e articoli scientifici sull'impiego del Polline nelle affezioni della PROSTATA.

1. A Pollen Extract in Patients with Inflammatory Chronic Prostatitis-Chronic Pelvic Pain Syndrome: A Multicentre, Randomised, Prospective, Double-Blind, Placebo-Controlled Phase 3 Study.
   Wagenlehner FM, Schneider H, Ludwig M, Schnitker J, Brähler E, Weidner W. Eur Urol. 2009 Jun 3.
    

2. Apitherapy: usage and experience in german beekeepers.
   Hellner M, Winter D, von Georgi R, Münstedt K.
   Evid Based Complement Alternat Med. 2008 Dec;5(4):475-9. Epub 2007 Jun 30.
    

3. Diagnosis and management of benign prostatic hyperplasia.
   Edwards JL. Am Fam Physician. 2008 May 15;77(10):1403-10.
    

4. [Phytotherapy of benign prostatic hyperplasia]
   Bracher F. Urologe A. 1997 Jan;36(1):10-7. 
    

5. Identification of a prostate inhibitory substance in a pollen extract.
   Habib FK, Ross M, Lewenstein A, Zhang X, Jaton JC.
   Prostate. 1995
    

6. [Status of phytotherapeutic drugs in treatment of benign prostatic hyperplasia]
   Dreikorn K, Schönhöfer PS. Urologe A. 1995 Mar;34(2):119-29.
    

7. Isolation and characterization of a cyclic hydroxamic acid from a pollen extract, which inhibits cancerous cell growth in vitro.
   Zhang X, Habib FK, Ross M, Burger U, Lewenstein A, Rose K, Jaton JC. - J Med Chem. 1995 Feb 17;38(4):735-8.
    

8. Results of treatment with pollen extract in chronic prostatitis and prostatodynia.
   Rugendorff EW, Weidner W, Ebeling L, Buck AC.
   Br J Urol. 1993 Apr;71(4):433-8.
    

9. [Inhibition of arachidonic acid cascade by extract of rye pollen]
   Loschen G, Ebeling L.
   Arzneimittelforschung. 1991 Feb;41(2):162-7.
    

10. Treatment of outflow tract obstruction due to benign prostatic hyperplasia with the pollen extract, cernilton. A double-blind, placebo-controlled study.
    Buck AC, Cox R, Rees RW, Ebeling L, John A.
    Br J Urol. 1990 Oct;66(4):398-404.
     

11. In vitro evaluation of the pollen extract, in the regulation of prostate cell growth.
    Habib FK, Ross M, Buck AC, Ebeling L, Lewenstein A.
    Br J Urol. 1990 Oct;66(4):393-7.
     

12. "Pollen and the Prostate". 5-7 February 1988, Vendig]
    Fortschr Med Suppl. 1988;50:1-18.
     

13. [Clinical application of PPC for nonspecific chronic prostatitis]
    Okada S, Hamada K, Takasaki N, Demura A, Okano H, Kirime S, Noda H, Ono S, Akita Y, Nishimoto K.
    Hinyokika Kiyo. 1985 Jan;31(1):179-85.
     

14. [Clinical evaluation of Cernilton on benign prostatic hyperplasia]
    Ueda K, Jinno H, Tsujimura S.
    Hinyokika Kiyo. 1985 Jan;31(1):187-91.
     

15. A steroid fraction of chloroform extract from bee pollen of Brassica campestris induces apoptosis in human prostate cancer PC-3 cells.
    Wu YD, Lou YJ. - Phytother Res. 2007 Nov;21(11):1087-91.
     

16. Brassinolide, a plant sterol from pollen of Brassica napus L., induces apoptosis in human prostate cancer PC-3 cells.
    Wu YD, Lou YJ.
    Pharmazie. 2007 May;62(5):392-5.
     

17. Down-regulation of prostate specific antigen in LNCaP cells by flavonoids from the pollen of Brassica napus L.
    Han HY, Shan S, Zhang X, Wang NL, Lu XP, Yao XS.
    Phytomedicine. 2007 May;14(5):338-43. Epub 2006 Nov 7.
     

19. Phytotherapy for benign prostatic hyperplasia.
    Gerber GS.
    Curr Urol Rep. 2002 Aug;3(4):285-91.
     

20. [Clinical evaluation of the effect of tamsulosin hydrochloride and cernitin pollen extract on urinary disturbance associated with benign prostatic hyperplasia in a multicentered study]
    Aoki A, Naito K, Hashimoto O, Yamaguchi M, Hara Y, Baba Y, Wada T, Joko K, Nagao K, Yamakawa G, Suyama K, Nagata K, Matsuyama H, Hirao H, Shimizu Y, Hironaka H, Isoyama R, Takemoto M, Tuchida M, Shiraishi K, Kato M, Kamiryo Y, Harada H, Otsuka T, Mitsui H, Nasu T, Hayashida S, Jojima K, Sacho T, Koshido Y, Harada N.
    Hinyokika Kiyo. 2002 May;48(5):259-67.
     

21. Effect of cernitin pollen-extract on experimental nonbacterial prostatitis in rats.
    Kamijo T, Sato S, Kitamura T.
    Prostate. 2001 Oct 1;49(2):122-31.
     

22. Cernilton for benign prostatic hyperplasia.
    Wilt T, Mac Donald R, Ishani A, Rutks I, Stark G.
    Cochrane Database Syst Rev. 2000;(2):CD001042. Review.
     

23. A systematic review of Cernilton for the treatment of benign prostatic hyperplasia.
    MacDonald R, Ishani A, Rutks I, Wilt TJ.
    BJU Int. 2000 May;85(7):836-41.
     

24. Review of recent placebo-controlled trials utilizing phytotherapeutic agents for treatment of BPH.
    Lowe FC, Dreikorn K, Borkowski A, Braeckman J, Denis L, Ferrari P, Gerber G, Levin R, Perrin P, Senge T.
     

25. A Pollen Extract (Cernilton) in Patients with Inflammatory Chronic Prostatitis–Chronic Pelvic Pain Syndrome: A Multicentre, Randomised, Prospective, Double-Blind, Placebo-Controlled Phase 3 Study
    European Urology, Volume 56, Issue 3, September 2009, Pages 544-551
    Florian M.E. Wagenlehner, Henning Schneider, Martin Ludwig, Jörg Schnitker, Elmar Brähler, Wolfgang Weidner
    
    Twelve weeks of a pollen extract (Cernilton) in men diagnosed with inflammatory National Institutes of Health (NIH) category III prostatitis/chronic pelvic pain syndrome (CP/CPPS) resulted in a significantly higher symptom improvement compared to placebo and was well tolerated. Pollen extract can therefore be recommended for patients with CP/CPPS in the dosage and duration studied.
     

26. Antioxidant effects of flavonoid from Croatian Cystus incanus L. rich bee pollen
    Food and Chemical Toxicology, Volume 47, Issue 3, March 2009, Pages 547-554
    Ana Šarić, Tihomir Balog, Sandra Sobočanec, Borka Kušić, Višnja Šverko, Gordana Rusak, Saša Likić, Dragan Bubalo, Barbara Pinto, Daniela Reali, Tatjana Marotti
     

27. Phytotherapy for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
    The Journal of Urology, Volume 179, Issue 6, June 2008, Pages 2119-2125 - Raj C. Dedhia, Kevin T. McVary
     

28. Bioactivity of Greek honey extracts on breast cancer (MCF-7), prostate cancer (PC-3) and endometrial cancer (Ishikawa) cells: Profile analysis of extracts
    Food Chemistry, Volume 116, Issue 3, 1 October 2009, Pages 702-708
    Anna V. Tsiapara, Mari Jaakkola, Ioanna Chinou, Konstadia Graikou, Tiina Tolonen, Vesa Virtanen, Paraskevi Moutsatsou
     

29. Anticancer and antiproliferative activity of natural brassinosteroids
    Phytochemistry, Volume 69, Issue 2, January 2008, Pages 418-426 Jana Malíková, Jana Swaczynová, Zdeněk Kolář, Miroslav Strnad
     

30. Complementary and alternative medicine: Herbs, phytochemicals and vitamins and their immunologic effects
    Journal of Allergy and Clinical Immunology, Volume 123, Issue 2, February 2009, Pages 283-294.e10
    Timothy Mainardi, Simi Kapoor, Leonard Bielory
     

31. Quality of life and complementary and alternative medicine use among cancer patients in Turkey
    European Journal of Oncology Nursing, In Press, Corrected Proof, Available online 22 April 2009
    Gulbeyaz Can, Ozgul Erol, Adnan Aydiner, Erkan Topuz
     

Bibliografia